arrow_back Back to App

Suboxone Review: Potential Changes in Availability and Regulations

This act mandates a scientific and medical review of Suboxone (buprenorphine-naloxone), used in addiction treatment. The goal is to assess if current regulations for this medication are still appropriate. This could impact how the drug is accessed and prescribed to patients in the future.
Key points
The Department of Health and Human Services will review current scientific and medical data on Suboxone.
The Attorney General, based on these findings, may change the drug's classification rules, affecting its availability.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_4053
Sponsor: Rep. Kuster, Ann M. [D-NH-2]
Process start date: 2023-06-13